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Rab3D, a member of the Rab3 subfamily of the Rab/ypt GTPases, is expressed on zymogen granules in the
pancreas as well as on secretory vesicles in mast cells and in the parotid gland. To shed light on the function
of Rab3D, we have generated Rab3D-deficient mice. These mice are viable and have no obvious phenotypic
changes. Secretion of mast cells is normal as revealed by capacitance patch clamping. Furthermore, enzyme
content and overall morphology are unchanged in pancreatic and parotid acinar cells of knockout mice. Both
the exocrine pancreas and the parotid gland show normal release kinetics in response to secretagogue
stimulation, suggesting that Rab3D is not involved in exocytosis. However, the size of secretory granules in both
the exocrine pancreas and the parotid gland is significantly increased, with the volume being doubled. We
conclude that Rab3D exerts its function during granule maturation, possibly by preventing homotypic fusion
of secretory granules.
Rab proteins are small GTPases that belong to the Ras
protein superfamily and that function in membrane traffic. In
Saccharomyces cerevisiae, 11 members of the Rab family (also
referred to as ypt/sec4 proteins) are known that operate in
distinct intracellular trafficking steps (40). In the human ge-
nome, 60 genes coding for Rab proteins have been identified
(12).
In recent years, major progress has been made in unraveling
the GTP-GDP cycle of Rab proteins. Like Ras, Rab proteins
contain an effector domain that undergoes major conforma-
tional changes during GTP hydrolysis (44, 53). Cycling be-
tween the GTP and GDP form requires additional proteins
including GTPase-activating proteins and guanine nucleotide
exchange factors (for recent reviews see references 46, 52, and
57). Furthermore, the GTP-GDP cycle is linked to membrane
association and dissociation, which involve proteins such as
GDP dissociation inhibitor (GDI) and membrane receptors
such as Yip proteins. Generally, the GTP form of Rab proteins
is considered to be the active form that specifically interacts
with effector proteins. For several Rabs such effector proteins
have been identified, but in many cases their function is not
understood. An increasing body of evidence suggests that in-
dividual Rab proteins may interact with multiple effectors that
are structurally diverse and that may control different reactions
in membrane traffic.
The first clues to the function of Rabs were obtained from
yeast mutants with defects in various Rab/ypt proteins. Such
defects generally resulted in the accumulation of vesicles at
different stages in membrane traffic, suggesting that they are
required for membrane fusion. Subsequent studies revealed
that Rabs most probably are involved in the initial binding of
membranes destined to fuse, a process generally referred to as
tethering. According to this view, Rab proteins exert their
function before the actual fusion reaction.
Rab3A is one of the best-characterized Rab proteins. In
mammals, three additional isoforms are expressed which are
referred to as Rab3B, Rab3C, and Rab3D. Rab3A, Rab3B,
and Rab3C are predominantly expressed in the nervous system
(21, 33), where they are localized to synaptic vesicles. Surpris-
ingly, Rab3A is not essential, since its deletion in mice resulted
in a relatively mild phenotype (22). It is unlikely that this is due
to isoform redundancy since, in Caenorhabditis elegans, which
contains only one Rab3 isoform, Rab3 is also not essential,
although more pronounced effects on synaptic function and
synaptic morphology were observed (39). Electrophysiological
analysis of synaptic transmission in neurons of Rab3A-defi-
cient mice revealed that neither the size nor the refilling rate of
the readily releasable pool was changed. In contrast, more
exocytotic events were observed in response to stimulation,
which resulted in an enhanced rundown of synaptic transmis-
sion (23). These findings are difficult to reconcile with a func-
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tion of Rab3 in vesicle tethering at the synapse but suggest
rather a function intimately associated with fusion. The readily
releasable pool represents vesicles that are attached to the
plasma membrane and primed for fusion, a pool that is ex-
pected to be reduced when tethering is defective.
Unlike Rab3A, Rab3B, and Rab3C, Rab3D is predomi-
nantly expressed outside the nervous system. Originally iden-
tified in fat cells (7), Rab3D protein is present in several
additional cell types, including secretory cells such as pancre-
atic (42, 55) and parotid (42) acinar cells, mast cells (41), and
peptide-secreting cell lines (9). In secretory cells, Rab3D ap-
pears to be predominantly localized to secretory granules, thus
mirroring the distribution of Rab3A in neurons and neuroen-
docrine cells. However, in cell types expressing both Rab3A
and Rab3D, such as adipocytes, AtT20 cells, and mast cells
(RBL-2H3), the two Rab3 forms appear to be differentially
localized (8, 36, 49).
Several approaches were made to address the function of
Rab3D. In RBL cells (a mast cell line) (15, 49) and AtT20 cells
(9), overexpression of wild-type Rab3D or a variant deficient in
guanine nucleotide binding results in a reduction of evoked
exocytosis. Furthermore, the number of granules close to the
plasma membrane was reduced whereas (at least in PC12 cells)
overexpression of wild-type protein had the opposite effect,
suggesting that Rab3D may be involved in vesicle-membrane
interactions, i.e., well before membrane fusion (35). In another
approach a transgenic mouse line was created in which Rab3D
was selectively overexpressed in the exocrine pancreas, yielding
approximately twofold-increased levels of the protein (43).
The initial rate of secretagogue-induced enzyme release was
doubled in the overexpressing line but reached normal levels
after 30 min of stimulation. Together, these results suggest that
Rab3D exerts a stimulatory role on exocytosis in various non-
neuronal cells, although it is not clear whether the protein is
involved in vesicle fusion, vesicle docking, or vesicle matura-
tion.
To shed light on the role of Rab3D, we have now knocked
out the Rab3D gene in mice. Surprisingly, Rab3D-deficient
mice were viable and fertile and showed no obvious defects. In
particular, both kinetics and dose response of secretagogue-
induced enzyme secretion of the pancreas were normal. Fur-
thermore, no difference was observed in mast cell degranula-
tion as monitored by capacitance patch clamping. However,
electron microscopy revealed that the size of secretory gran-
ules in both the exocrine pancreas and the parotid gland is
significantly increased, with the volume being doubled, sug-
gesting that Rab3D functions in granule maturation but not in
exocytotic membrane fusion.
MATERIALS AND METHODS
Antibodies. Monoclonal antibodies specific for Rab3A (Cl42.2 [37]), syncollin
(Cl87.1 [2]), synaptobrevin 2 (Cl69.1 [16]), GDI (Cl81.1 [14]), and rabphilin
(clone Cl76.2 [5]) as well as polyclonal antibodies specific for Rab3B (O. M.
Schluetter et al., unpublished data); Rab3C (20); endobrevin (19); and syntaxins
2, 3, 4, 7, and 13 were described previously (4, 5, 25) and are commercially
available from Synaptic Systems (Go¨ttingen, Germany). Cellubrevin (3) and
syntaxin 8 (4) antisera were described previously.
Antibodies specific for secretory carrier membrane protein (SCAMP) and
synaptosome-associated protein 23 (SNAP-23) were obtained from Synaptic
Systems. Antibodies specific for -tubulin and syntaxin 6 were obtained from
Sigma, (Deisenhofen, Germany) and from Transduction Laboratories (San Di-
ego, Calif.), respectively.
A rabbit serum specific for Rab3D (no cross-reactivity toward other Rab3
isoforms) was raised against a synthetic C-terminal peptide (C-NGKPALGDT
P).
Generation of Rab3D-deficient mice. Rab3D mutant mice were generated by
homologous recombination in embryonic E14.1 stem cells derived from the
mouse line 129Sv/J as described before (51). In short, three genomic clones
containing coding exons of murine Rab3D were isolated from a FixIISV129
mouse genomic library (Stratagene, La Jolla, Calif.) by standard techniques. The
gene-targeting vector based on these clones replaced the first exon of Rab3D
(amino acids 1 to 76; see Fig. 1) with a neomycin resistance cassette. A 4.4-kbp
BamHI-NotI fragment was cloned into the same sites of pTKneo3A. A 4.7-kbp
blunt-ended ClaI/NotI fragment was ligated into the polished ClaI site of the
vector. Following electroporation and selection, recombinant stem cells were
analyzed by Southern blotting. For hybridization, an outside probe localized 3 of
the targeting vector short arm was used. Positive clones were injected into
C57BL6/J mouse blastocysts to obtain highly chimeric mice that transmitted the
mutation through the germ line. Germ line transmission was confirmed by
Southern blotting. Subsequent genotyping was performed by PCR with primer
pairs specific for the wild-type allele (5-GCCATCTCTCCAGCCCTTGTTT
GTC and 5-CTCCAGTTATGTAGGCAAGGCTAGCC) or the mutant allele
(5-CCTGTCCGGTGCCCTGAATGAA and 5-GCCGATCCCCTCAGAAGA
AC), both generating fragments of 550 bp. Mice were backcrossed to C57BL6/J
mice, bred, and maintained by standard mouse husbandry procedures.
Electrophysiological analysis of mast cells. Mast cells were obtained essen-
tially as described elsewhere (1, 21) from wild-type and Rab3D-knockout (KO)
mice by peritoneal lavage with buffer A (140 mM NaCl, 10 mM HEPES-NaOH,
2 mM CaCl2, 1 mM MgCl2, 6 mM glucose, and 45 mM NaHCO3, pH 7.2). Cells
were plated on coverslips and incubated in an atmosphere of 5% CO2–95% air
until use (between 1 and 8 h after culture). All experiments were performed at
room temperature in buffer A without NaHCO3; glucose was added to adjust the
osmolarity. Patch pipette solutions contained 140 mM potassium glutamate, 10
mM HEPES, 7 mM MgCl2, 3 mM KOH, 0.2 mM Mg-ATP, 2.5 mM K2-EGTA,
and 7.5 mM Ca-EGTA. The final Ca2 concentration was between 500 and 900
nM. We added 5 M GTPS to the pipette solution to induce degranulation.
Mast cells were identified, and degranulation was visually monitored with an
inverted microscope (IM-35; Zeiss) equipped with Nomarski optics. Membrane
capacitance was measured by whole-cell recordings (24). The C-slow and G-
series potentiometers of an EPC-8 (Heka Electronics) patch clamp amplifier
were used to cancel out the incoming membrane current in order to resolve small
capacitance changes. Direct readout of these knobs gave us the approximations
for the initial and final cell membrane capacitance and series conductance of
every cell. We obtained a calibration signal by unbalancing the C-slow potenti-
ometer by 100 fF, corresponding to a change of 10 m2 (assuming a specific
membrane capacitance of 1 F/cm2 of membrane). The V-command was a
50-mV sine wave (root mean square, 1 kHz). Capacitance and conductance
values were estimated from the real and imaginary components of the complex
admittance, which was obtained by a Lock-In amplifier (SR-830; Stanford Re-
search) (34). Data acquisition was done using an IDA 15125 board (INDEC
Systems) programmed in Visual Basic. One data point was obtained every 2.5 ms.
Data analysis was done with IGOR Pro 4.01 (Wavemetrics). Vesicle radii were
calculated assuming that a vesicle is spherical and its specific membrane capac-
itance is 1 F/cm2.
Electron microscopy. To perform morphological studies, 600-nm-thick sec-
tions of EMbed 812 (Plano)-embedded tissue, described below, were stained
with toluidine blue and visualized in a Zeiss light microscope.
For transmission electron microscopy pieces of pancreas no larger than 2 mm3
were fixed by immersion with 2% glutaraldehyde in 0.1 M cacodylate buffer at
pH 7.4. After postfixation in 1% osmium tetroxide on ice and preembedding
staining with 1% tannic acid and 1% uranyl acetate, tissue samples were dehy-
drated and embedded in EMbed 812. Thin sections were counterstained with
lead citrate and examined with a Philips CM 120 BioTwin transmission electron
microscope (Philips Inc., Eindhoven, The Netherlands). Images were taken with
a 1K slow-scan charge-coupled device camera (GATAN, Inc.).
Purified zymogen granules from a sucrose gradient (see below) were centri-
fuged for 10 min at 4,000 rpm in a Biofuge (Heraeus). The pellet was diluted with
40 l of 2% agarose in 0.1 M cacodylate buffer at pH 7.4. Small pieces of the
agarose-immobilized granules were cut and used for an EMbed embedding as
described above.
Image analysis. The diameters of zymogen granules were measured on digital
images taken at the eucentric height at the same magnification and defocus with
DigitalMicrograph 3.4 (GATAN, Inc.). Since the shape of the zymogen granules
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is elliptical, the short (a) and the long (b) diameters of the granules were
measured perpendicular to the membrane. The distribution of the vesicle diam-
eters was done with the mean diameters c  (a  b)/2. Only organelles with
clearly delineated membranes were measured. The mean diameters of all mea-
sured vesicles were corrected by the estimated section thickness of 80 nm by
using the theoretical solution given by reference 45. For each calculation sections
from two different animals were analyzed.
Subcellular fractionation. Small synaptic vesicles (LP2 fraction) from brain
(28) and zymogen granules from pancreas (38) were prepared in the presence of
0.1 mM GTPS. To enrich for membrane proteins, phase partitioning in Triton
X-114 was performed on homogenate fractions (13). For immunoblotting with
antibodies specific for syntaxin 2, syntaxin 3, syntaxin 4, syntaxin 7, syntaxin 13,
syntaxin 6, syntaxin 8, endobrevin, cellubrevin, SNAP-23, and Rab3D, an aliquot
of the detergent phase corresponding to 200 g of protein of the starting ho-
mogenate was loaded per lane, and for SCAMP and synaptobrevin 2, aliquots
corresponding to 50 g of protein of the starting homogenate were loaded per
lane. For immunoblotting with antibodies specific for GDI, N-ethylmaleimide-
sensitive fusion protein (NSF), rabphilin, syncollin, and -tubulin, 20 g of
homogenate was loaded per lane. Signals were quantified with enhanced chemi-
luminescence reagent (NEN, Boston, Mass.) and an Image Reader LAS-1000 in
combination with AIDA software (Raytest) (see Table 1).
For isopycnic sucrose density gradient centrifugation, zymogen granules were
prepared as described previously (38). Zymogen granules derived from one
pancreas were resuspended in 300 l of homogenization buffer (280 mM sucrose,
5 mM morpholineethanesulfonic acid [MES; pH 6.5], 1 mM EDTA, 0.1 mM
phenylmethylsulfonyl fluoride [PMSF], 10 g of soybean trypsin inhibitor/ml, 1
g of pepstatin/ml, 11 g of benzamidine/ml, 1 g of antipain/ml, 1 g of
leupeptin/ml), loaded on top of a continuous sucrose gradient (10 ml of 35 to
60% [wt/vol] sucrose in 5 mM MES [pH 6.5]–1 mM EDTA–0.1 mM PMSF–1 g
of soybean trypsin inhibitor/ml–0.1 g of pepstatin/ml–1.1 g of benzamidine/
ml–0.1 g of antipain/ml–0.1 g of leupeptin/ml), and centrifuged for 19 h at
40,000 rpm in a Beckman (Fullerton, Calif.) SW41 rotor. After centrifugation
fractions of 300 l were collected. All samples were analyzed for amylase (by
enzyme assay; see below) (Fig. 1B), for SCAMP and synaptobrevin 2 (by immu-
noblotting), and for size distribution (by electron microscopy; see above) (see
Fig. 5 and 6). The sucrose concentration of each fraction was determined by
refractometry.
Secretion of amylase. Secretion was monitored by measuring the release of
amylase from pancreatic and parotid lobules (prepared according to the method
of reference 50) in response to carbamylcholine and isoproterenol, respectively.
For each incubation 20 to 30 lobules were suspended in oxygen-saturated incu-
bation buffer consisting of 20 mM HEPES (pH 7.4), 120 mM NaCl, 5 mM KCl,
1.2 mM MgCl2, 2 mM CaCl2, 14 mM glucose, Eagle’s minimal essential medium
amino acid supplement, and 2 mM L-glutamine. Amylase discharge into the
incubation medium was expressed as percentage of total amylase content in the
lobules at the beginning of the incubation.
Protein synthesis and transport. To measure discharge of radioactively la-
beled proteins, lobules were incubated for 10 min in Dulbecco modified Eagle
medium supplemented with amino acids and 500 Ci of 3H-labeled amino acids
(TRK440; Amersham)/ml, washed, and transferred into unlabeled medium.
Where indicated, the medium contained 0.5 M carbachol. At the indicated time
points, aliquots of medium and lobules were removed, and the lobules were
homogenized in lysis buffer (20 mM Tris-HCl [pH 9.0], 0.01% Triton X-100, 0.1
mM PMSF, 1 g of soybean trypsin inhibitor/ml, 0.1 g of pepstatin/ml, 1.1 g
of benzamidine/ml, 0.1 g of antipain/ml, 0.1 g of leupeptin/ml). Protein syn-
thesis was measured by determination of trichloroacetic acid-insoluble radioac-
tivity of the homogenate samples normalized to the DNA content. Discharge of
labeled protein was measured by quantifying the trichloroacetic acid-insoluble
radioactivity of the medium. In all cases, radioactivity was determined by liquid
scintillation counting. In all experiments, lactate dehydrogenase released into the
medium remained constant during the incubation time, showing that protein
release is not caused by nonspecific tissue damage.
Other methods. Trypsin was measured after activation by enterokinase (50)
according to the method in reference 27 using N-benzoyl arginine ethyl ester as
substrate. Chymotrypsin was assayed after activation by trypsin with benzoyl
tyrosine ethyl ester as substrate (27). Amylase was measured according to the
method in reference 11, and lactate dehydrogenase was measured according to
the method in reference 10. Protein was determined by the bicinchoninic acid
method (Pierce) according to the instructions of the manufacturer. All enzyme
activities were normalized to the DNA content (determined according to the
method in reference 48) of the homogenate.
RESULTS
A murine genomic library was screened with mouse Rab3D
cDNA as a probe to isolate genomic clones of the murine
Rab3D locus. Three independent clones were isolated which
contained the first coding exon of mouse Rab3D.
The targeting vector for homologous recombination re-
placed exon 1 (coding for residues 1 to 76 of Rab3D) with a
neomycin resistance cassette (Fig. 1A). Electroporation of the
targeting vector into E14.1 mouse embryonic stem cells (26)
resulted in clones in which homologous recombination of the
Rab3D gene had occurred. Chimeric mice were generated by
blastocyst injection with one of the stem cell clones. These
mice were used for breeding to generate heterozygous mutant
mice. Interbreeding of the heterozygous mice resulted in off-
spring that showed the predicted Mendelian frequencies of
wild-type, heterozygous, and homozygous genotypes.
Mice lacking the Rab3D gene were viable and fertile and
exhibited no obvious phenotypic changes. Mutant mice were
capable of reproducing and of caring for their offspring. Their
body weights and their life spans were comparable to those of
their wild-type and heterozygous littermates. To confirm that
no Rab3D protein was expressed, we performed an immuno-
blot analysis of pancreatic zymogen granules, isolated from
adult mice, which are known to be enriched in Rab3D protein
(Fig. 1B). Rab3D was not detectable in homozygous mutants,
whereas the levels of synaptobrevin and SCAMP, two integral
membrane proteins of zymogen granules, were normal. Fur-
thermore, Rab3A, Rab3B, and Rab3C were not detectable in
wild-type or Rab3D-deficient mice, whereas a synaptic vesicle
preparation from mouse brain showed strong signals for these
three Rab3 isoforms.
As outlined in the introduction, both the localization of
Rab3D to secretory organelles and previous functional studies
strongly suggest that the protein plays an important role in
regulated exocytosis. We have therefore concentrated our
analysis on secretory cells, focusing on mast cells and exocrine
glands in which such a role was inferred from previous studies.
Peritoneal mast cells were isolated from mutant and wild-type
mice. When analyzed by light microscopy, the two cell popu-
lations were similar and exhibited no obvious morphological
alterations (data not shown). To investigate whether exocytosis
was affected, we performed whole-cell capacitance patch
clamping experiments. This procedure not only allows for high
kinetic resolution of release but also permits an accurate de-
termination of the vesicle size. Degranulation was induced by
GTPS, which was included in the pipette solution (see Ma-
terials and Methods). As shown in Fig. 2A and B, no difference
in the kinetics of exocytosis was observed between mast cells
derived from Rab3D-deficient mice and littermate controls.
Furthermore, Rab3D-deficient mast cells appeared to possess
a normal inventory of granules, since the relative capacitance
increase (which is a measure of the total surface area of all
exocytosed granules with respect to the cell size) was not
changed. We also compared the size distribution of individual
capacitance step increases (Fig. 2C and D), which are a direct
measure of vesicle size (Fig. 2E and F). Again, no significant
differences were observed between Rab3D-deficient and con-
trol cells. We conclude that, in contrast to previous assump-
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tions, Rab3D is not involved in mast cell degranulation or in
the establishment of secretion-competent vesicle pools.
We next investigated whether the function of exocrine
glands is affected in Rab3D-deficient mice, with the main em-
phasis being on the exocrine pancreas. In pancreatic acinar
cells, Rab3D is localized on the membrane of zymogen gran-
ules (42, 55). Upon stimulation, the protein has previously
been shown to undergo major redistribution to recycling mem-
branes but appears to be absent from the apical plasma mem-
brane (32). These data suggested that membrane dissociation,
and thus perhaps also GTP hydrolysis, is associated with exo-
cytosis and thus may be involved in its regulation.
No obvious gross morphological changes were observable in
the pancreata of Rab3D-deficient mice. From both the pan-
creas and the parotid glands of 90-day-old homozygous mutant
mice semithin sections were prepared that were stained with
toluidine blue. Upon microscopic examination, the tissues
showed normal acinar morphology with no sign of inflamma-
tion (data not shown). Furthermore, no significant difference
was observed in the levels in tissue of several proteins involved
in membrane traffic including synaptobrevin 2, cellubrevin, en-
dobrevin, SNAP-23, several syntaxins, SCAMP, NSF, GDI,
and rabphilin and as controls -tubulin and syncollin (Table 1).
These data suggest that the lack of Rab3D has no direct or
indirect effect on the expression levels of other trafficking pro-
teins, in good agreement with similar findings with Rab3A-KO
mice (22)
Next, we evaluated whether secretagogue-induced secretion
was changed. Pancreatic lobules were prepared and amylase
release was examined by standard procedures (50). No differ-
ence in the dose response to the secretagogue carbachol was
observed between Rab3D-deficient mice and littermate con-
trols showing a maximum at a carbachol concentration of 0.5
M (Fig. 3A). To exclude differences in the release kinetics,
the time dependence of amylase release was monitored. As
shown in Fig. 3B, no differences in basal and evoked secretion
were found regardless of whether lobules were stimulated by
submaximal (0.1 M) or maximal (0.5 M) carbachol concen-
trations. We also tested whether Rab3D is involved in the
control of amylase release in the parotid gland as suggested by
several previous publications (42, 47). However, again no dif-
ferences in the extent of evoked amylase release were observed
between Rab3D-deficient mice and littermate controls when
secretion was stimulated for 60 min with an 0.3 M concen-
tration of the -adrenergic agonist isoproterenol: 81.9% of
total amylase was released in wild-type mice versus 80.1% in
Rab3D-deficient mice (n  4 for each genotype with a range of
78.2 to 84.2% for wild-type mice and 76.6 to 83.3% for KO
mice). Similarly, basal secretion over a period of 60 min was
FIG. 1. (A) Gene targeting strategy for the generation of
Rab3D-KO mice. Maps of the targeting vector and the resulting mu-
tant gene are shown. Positions of exon 1 (black box with amino acids
encoded by corresponding cDNA) and restriction enzyme sites are
indicated. neo, neomycin resistance gene; TK, thymidine kinase gene.
(B) Rab3D protein is lacking in homozygous Rab3D-KO mice. Syn-
aptic vesicles from brain and zymogen granules from the pancreas
were isolated from adult wild-type (/) and homozygous (/) mice
and analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and immunoblotting (20 g/lane) with antibodies specific for
Rab3A, Rab3B, and Rab3C and for SCAMP and synaptobrevin 2 (syb)
as a marker for synaptic vesicle and zymogen granule membranes.
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FIG. 2. Exocytosis and granule size of mast cell granules, measured as step increase of membrane capacitance, are unchanged in Rab3D-
deficient mice. (A and B) Representative traces of vesicle fusion in mast cells isolated from wild-type and Rab3D-deficient mice, respectively.
Stepwise increases of membrane capacitance typically identify exocytotic events of single vesicles. (C to F) Size distributions of secretory vesicles.
Panels C and D show step size histograms of discrete and irreversible increases of membrane capacitance (wild-type [WT] cells [C], 21.3 	 0.27
fF [mean 	 standard error of the mean], n  1,186; mutant cells [D], 23.15 	 0.32 fF, n  799). Panels E and F show the distribution of vesicle
radii (wild-type cells [E], 0.40 	 0.002 m, n  1,186; mutant cells [F], 0.42 	 0.003 m, n  799). Data were obtained from seven cells derived
from two wild-type mice and six cells from two mutant mice. (G) Initial plasma membrane capacitance in mast cells measured immediately before
intracellular stimulation of exocytosis with GTPS (wild-type cells, 6.22 	 0.55 pF [mean 	 standard error of the mean], from 14 cells derived from
two mice; mutant cells, 6.17 	 0.42 pF, from 17 cells derived from three mice). (H) Final cell membrane capacitance after stimulation of exocytosis
with GTPS (wild-type cells, 18.46 	 2.04 pF, from 13 cells derived from two mice; mutant cells, 17.80 	 1.12 pF, from 17 cells derived from three
mice).
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low in unstimulated wild-type and Rab3D-deficient mice (both
14.9%; n  4 for each genotype with a range of 12.6 to 16.1%
for wild-type and 13.7 to 17.2% for KO mice).
While these results exclude a direct involvement of Rab3D
in exocytosis, it is conceivable that Rab3D is involved at an
earlier step in granule biogenesis, which under our experimen-
tal conditions was not rate limiting and thus would not become
apparent in the release assays. We therefore used established
protocols to determine the intracellular transport rate of newly
synthesized zymogens. Pancreatic lobules were pulse-labeled
for 5 min with radioactive amino acids, washed, and trans-
ferred to unlabeled medium, followed by incubation in either
the presence or the absence of the secretagogue carbachol. At
different time points, the amount of labeled protein was de-
termined in the medium and in the tissue.
Basal discharge of radiolabeled protein was low in unstimu-
lated controls of both wild-type and KO mice (Fig. 4A). Fur-
thermore, no difference in the secretion of labeled protein was
observed in the presence of 0.5 M carbachol. In both wild-
type and Rab3A-deficient mouse lobules, discharge of labeled
protein commenced 30 min after the beginning of incubation.
As expected, the levels in tissue of radiolabeled proteins
showed an inverse relationship. After reaching a plateau, the
levels in tissue remained unchanged over the entire incubation
period in unstimulated control incubations. In the carbachol-
containing incubation mixtures, levels in tissue started to de-
crease after 30 min in lobules prepared from wild-type and
Rab3D-deficient mice (Fig. 4B). Together these data show that
the intracellular transit time of secretory proteins is unchanged
in Rab3D-deficient mice.
We also checked whether the polarity of exocytosis is af-
fected. Acinar cells exhibit a high polarity, and zymogen gran-
ules fuse only with the apical plasma membrane. When polarity
is disturbed such as in pancreatitis, zymogen granules also fuse
with the basolateral membrane, resulting in a measurable in-
crease in serum amylase concentration. However, we did not
detect any difference in the serum amylase levels between
wild-type (100% [72 to 123.3%]) and Rab3D-deficient (94.2%
[87.5 to 136.8%]) mice (also Fig. 5C and D).
The experiments described so far revealed no difference in
the functional parameters of the secretory pathway between
Rab3D-deficient and wild-type control mice. We therefore ex-
amined whether the structure of the organelles involved in the
secretory pathway was altered, with a special emphasis on
secretory granules where Rab3D is normally localized. Small
tissue pieces were prepared from randomly selected areas of
both the pancreas and the parotid gland. They were fixed by
immersion and then processed for transmission electron mi-
FIG. 3. Amylase release is unchanged in the pancreas of Rab3D-
deficient mice. Amylase release was measured with isolated pancreatic
lobules prepared from wild-type and KO mice. Secretion is expressed
as a percentage of amylase activity released into the medium with
respect to total amylase content (sum of amylase discharged in the
medium and amylase retained in the tissue). Each value represents the
mean of four independent experiments; bars indicate the range.
(A) Dose dependence of carbachol-induced amylase release. (B) Dis-
charge kinetics of amylase unstimulated and in response to 0.1 M and
0.5 M carbachol.
TABLE 1. Levels in pancreatic tissue of Rab3D and proteins
involved in membrane traffica
Protein
% (Range) of protein in mouse type:
/ /
Synaptobrevin 2 100 (96.3–103.4) 97.9 (92.9–105.2)
SNAP-23 100 (95.9–105.4) 120.1 (117.8–124.1)
Cellubrevin 100 (92.4–111.6) 92.2 (82.1–103.6)
Endobrevin 100 (94.1–104.4) 97.9 (95.4–99.5)
Syntaxin 7 100 (91.6–111.1) 102.2 (78.8–117.4)
Syntaxin 13 100 (90.1–117.2) 102.4 (90.1–112.7)
Syntaxin 8 100 (91.8–110.9) 106.8 (98.2–112.3)
Syntaxin 6 100 (85.3–109.6) 91.6 (81.5–98.2)
Syntaxin 2 100 (93.2–105.3) 99.3 (94.5–105.6)
Syntaxin 3 100 (98.3–102.9) 97.3 (90.9–102.9)
Syntaxin 4 100 (92.7–104.1) 94.1 (89.4–100.9)
SCAMP 100 (93.4–105.8) 102.3 (98.4–105.9)
Syncollin 100 (93.3–103.4) 98.5 (90.7–109.5)
NSF 100 (94.6–105.5) 95.5 (89.0–100.0)
GDI 100 (95.7–107.6) 97.9 (95.6–102.1)
-Tubulin 100 (94.4–106.8) 98.5 (87.8–106.7)
Rabphilin 100 (94.2–107.2) 97.6 (89.6–105.1)
Rab3D 100 (95.5–105.8) 3.9 (1.4–7.9)
a Pancreatic proteins derived from wild-type (/) and KO (/) mice (three
mice per group) were analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and quantitative immunoblotting. Signals were normalized to the
signal average of wild-type mice and are given as percentages.
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croscopy. As already inferred from light microscopic examina-
tion of tissue sections, the acini were normally organized and
displayed normal polarity. However, the secretory granules in
both the exocrine pancreas (Fig. 5C and D) and the parotid
gland (Fig. 5A and B) appeared to be larger in Rab3D-defi-
cient mice than in wild-type littermate controls. For quantita-
tion, a large number of granules, approximately 1,000 granules
each, were randomly selected from independent sections and
measured. As shown in the histograms of Fig. 6, the size dis-
tribution of the granules from pancreatic as well as parotid
acini was shifted to larger radii in Rab3D-deficient mice (Fig.
5B and D), with an average increase from 431 to 526 nm in the
pancreas and from 370 to 453 nm in the parotid gland. When
converted into volume, these increases amount to an average
doubling of the volume of the secretory granules in both exo-
crine glands.
According to the classical pathway worked out by Palade and
colleagues (44a), secretory granules in exocrine glands are
derived from the trans-Golgi network as large, irregularly
shaped vacuolar structures. These condensing vacuoles then
undergo further maturation involving an increase in intrave-
sicular protein concentration that is associated with a reduc-
tion in size. Size reduction involves the removal of membrane,
which is probably achieved by budding of small and empty
vesicles. The larger size of the secretory granules in Rab3D-
deficient mice may thus be due to a defect in granule matura-
tion. To test for this possibility, we performed isopycnic su-
crose density gradient centrifugation on preenriched zymogen
granule fractions of the pancreas. The density of mature zy-
mogen granules is largely determined by the intracellular pro-
tein concentration. If the doubling of the volume is due to a
maturation defect, the protein concentration within zymogen
granules of Rab3D-deficient mice would be expected to be
only half of that of normal mice, which should result in a
measurable reduction of their buoyant density.
As shown in Fig. 7, no change in the buoyant density was
observed in zymogen granules obtained from Rab3D-deficient
mice. To exclude the possibility that the high osmolarity of the
sucrose gradient solution influences the shrinkage of zymogen
granules derived from KO mice, the zymogen granule fractions
were collected from the gradient, pooled, and immediately
processed for electron microscopy. When the granule size dis-
tribution was determined, the same shift in the size distribution
was observed as in the pancreatic tissue (Fig. 6C). We conclude
that despite their larger size the density of zymogen granules is
not changed in Rab3D-deficient mice, suggesting that the in-
tragranular protein concentration corresponds to that of ma-
ture wild-type granules. To exclude the possibility that the
overall concentration of zymogen is increased, we determined
the pancreatic zymogen levels in Rab3D-deficient mice and
littermate controls. No significant differences were observed.
The levels of trypsin were unchanged and the levels of chymo-
trypsin, amylase, and total protein (all calibrated on the DNA
content) were slightly reduced in Rab3D-deficient mice (Table
2).
DISCUSSION
In the present study we have addressed the role of Rab3D by
generating Rab3D-KO mice. Our data document that the pro-
tein is not essential for survival or for basic performance of the
major organs. In contrast to previous assumptions, basal and
evoked secretion is normal in both mast cells and exocrine
glands, suggesting that the protein is obviously not involved in
a step crucial for the secretory pathway. Intriguingly, however,
we found that in Rab3D-deficient mice the size of enzyme-
containing secretory granules in both the pancreas and the
parotid gland is drastically increased, suggesting that the pro-
tein plays a role in granule maturation.
Due to its high homology to Rab3A, Rab3B, and Rab3C,
Rab3D (75.6% identity with Rab3A in mice) was considered to
be an isoform, particularly since all Rab3 proteins are localized
to secretory organelles involved in regulated exocytosis.
Rab3A, which is much better characterized than Rab3D, was
therefore assumed to be paradigmatic for all Rab3 isoforms.
Despite major efforts, the precise molecular step controlled by
Rab3A is still far from clear. The analysis of Rab3A-deficient
FIG. 4. Intracellular transport of proteins is not affected in the
pancreas of Rab3D-deficient mice. Pancreatic lobules derived from
wild-type and KO mice were incubated for 5 min in medium containing
3H-labeled amino acids. After chase to cold medium containing either
no stimulants (0 M) or 0.5 M carbachol, aliquots of the medium
(A) and the lobules (B) were removed as indicated, and trichloroacetic
acid-precipitable radioactivity was determined. The values were nor-
malized to the DNA content of the homogenates. Values are means of
two different animals; bars indicate the range.
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FIG. 5. Electron micrographs obtained from ultrathin sections of parotid gland (A and B) or pancreas (C and D) derived from wild-type (A
and C) and Rab3D-deficient (B and D) mice. Also shown are purified zymogen granules derived from a sucrose gradient from wild-type (E) and
Rab3D-deficient (F) mice. Bars, 7 (A to D) and 1 (E and F) m.
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mice suggests that the protein functions close to exocytosis
without influencing vesicle recruitment (23). While the pres-
ence of additional synaptic Rab3 isoforms in mice may influ-
ence the phenotype of Rab3A-deficient mice, only one Rab3
isoform has been identified in the nematode C. elegans (12).
Therefore, the KO phenotype should be free of problems
caused by isoform redundancy. Nematodes lacking functional
Rab3 are viable but are characterized by depressed neuro-
transmitter release (39). Furthermore, unlike in Rab3A-defi-
cient mice the number of synaptic vesicles in nerve terminals is
significantly reduced. Based on these findings, it was suggested
that Rab3 may regulate vesicle recruitment, but a function in
the fusion step cannot be excluded. Similar effects were also
observed for aex-3 (the Rab3 GDP-GTP exchange protein)
mutants in whom Rab3 is mislocalized (30), although Rab3-
independent function of aex-3 cannot be ruled out (31). It
should be noted that the function of Rab3 proteins has also
been investigated in secretory cell lines by using overexpression
of wild-type or mutant proteins deficient either in GTP hydro-
lysis or in guanine nucleotide binding (9, 29, 35, 49). A variety
of effects have been reported, including both inhibition and
FIG. 6. Secretory granules of the parotid gland and the pancreas
are enlarged in Rab3D-deficient mice. (A and B) The radii of granules
were measured in ultrathin sections from the parotid gland (A) and the
pancreas (B) by using images obtained with a slow-scan charge-cou-
pled device camera. Each data set represents a combination of values
obtained from two mice. The values were normalized to the total
number of granules. (C) Zymogen granules of Rab3D-deficient mice,
purified by sucrose gradient centrifugation, retain the increase in the
vesicle diameter after granule isolation.
FIG. 7. The buoyant density of zymogen granules is unchanged in
Rab3D-deficient mice. Fractions enriched in zymogen granules were
subjected to isopycnic sucrose density gradient centrifugation (closed
circles, wild-type mice; open circles, Rab3D-deficient mice). The gra-
dient was fractionated in 300-l aliquots, and the distribution of zy-
mogen granules was measured by determining the amylase content of
each fraction. Lines without circles indicate the sucrose concentration
of each fraction, determined by refractometry. The values are means of
two different experiments; the bars represent the range of the data
points. Filled circles, Rab3D-deficient mice; open circles, wild-type
controls.
TABLE 2. Protein and enzyme levels in the pancreata of wild-type
and Rab3D-deficient micea
Protein or enzyme
% (Range) in mouse type:
/ /
Protein 100 (76–130) 87 (75–94)
Chymotrypsin 100 (89–119) 67 (57–76)
Trypsin 100 (66–131) 96 (74–122)
Amylase 100 (70–123) 76 (64–85)
a /, wild type; /, Rab3D deficient. Protein levels and enzyme activities
were normalized to DNA content. Four mice of each genotype were analyzed.
The means of wild-type values were set to 100%.
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stimulation of exocytosis, but no coherent picture has emerged
from these studies.
In contrast to Rab3A, Rab3B, and Rab3C, Rab3D is predom-
inantly expressed in peripheral tissues where the other isoforms
either are expressed at low levels or are lacking. Thus, the effect
of Rab3D deletion should not be influenced by functional com-
pensation, at least not to a major extent. Surprisingly, deletion of
Rab3D has no effect on the kinetics or the extent of regulated
exocytosis, as documented by our analysis of exocytosis in mast
cells and exocrine glands. Thus, we conclude that the function of
Rab3D differs from that of Rab3A and from that of the only Rab3
isoform expressed in the nervous system of C. elegans. Two alter-
native explanations are possible. First, Rab3D, despite its se-
quence similarity to Rab3A, is structurally sufficiently different to
interact with different sets of proteins. Such proteins may include
the effectors or the proteins responsible for the recruitment of
Rab3A and Rab3D to specific subcellular compartments. Differ-
ences in localization between Rab3A and Rab3D were suggested
by localization studies of RBL and AtT20 cells (9, 49). Second,
the interacting proteins may not distinguish between Rab3A and
Rab3D, but their expression pattern varies between different tis-
sues, thus determining the specific cellular response to the Rab3
GTP-GDP cycle. For instance, the Rab3A effectors rabphilin and
RIM are predominantly expressed in the nervous system, and it is
conceivable that peripheral tissues contain other, hitherto-un-
known Rab3 effectors. Currently, we cannot distinguish between
these possibilities. Interestingly, rabphilin levels were not changed
in acinar cells of Rab3D-deficient mice whereas they are reduced
in neurons of mice lacking Rab3A (22).
Previous work suggested that Rab3D controls exocytosis in
mast cells (49). However, our analysis of mast cell degranula-
tion in Rab3D-deficient mice conclusively shows that neither
kinetics, vesicle size, nor the extent of exocytosis is altered.
Thus, we conclude that Rab3D has neither a direct nor an
indirect effect on mast cell exocytosis. In the study by Roa et al.
(49), overexpression of both wild-type and guanine-nucleotide-
binding-deficient Rab3D caused a reduction in hexosamini-
dase release. In light of our data, the specificity of these effects
needs to be reconsidered. Although experiments overexpress-
ing proteins are popular, the effects of Rab proteins, either
wild type or mutant, need to be interpreted with caution, par-
ticularly when they result in a loss of function.
The most conspicuous change in Rab3D-deficient mice is a
substantially increased size of the secretory granules, while the
intragranular protein concentration appears to be unchanged. It
should be noted that the size of the pancreas zymogen granules is
variable and depends on physiological and developmental factors.
For instance, in starved animals the diameter of zymogen gran-
ules is increased by about 20 to 30% (6, 18). We observed a
similar increase when comparing starved and fed mice. However,
this increase was evident in both wild-type and Rab3D-deficient
mice and thus is superimposed on the size difference caused by
Rab3D deletion (unpublished observations).
More interestingly, it has been known for many years that
during development of the pancreas the size of zymogen gran-
ules shrinks around birth (17), i.e., around the time the gland
acquires competence for regulated secretion (55). Rab3D is
expressed 2 days after the appearance of zymogen granules,
but it is not membrane associated until birth (56). In the light
of the results described here, it is likely that membrane binding
of Rab3D during the time of birth is directly responsible for
granular size reduction during development.
How does Rab3D regulate the size of secretory granules?
There are two possible explanations for this phenotype. First,
the size of condensing vacuoles budding off the trans-Golgi
network could be larger. In unstimulated glands, Rab3D is
predominantly localized to mature secretory granules with only
little labeling of the Golgi or trans-Golgi network region (32).
However, upon stimulation for 3 h most of the zymogen gran-
ules disappeared and Rab3D was then localized to newly form-
ing secretory vesicles on the trans-Golgi network, which would
be compatible with a role in determining the size of condensing
vacuoles. According to this scenario, all subsequent maturation
steps would be normal, but the initially larger size would carry
over to the final maturation steps.
Alternatively, the role of Rab3D may be to downregulate
fusion of secretory granules at a step subsequent to the for-
mation of condensing vacuoles. Although not previously re-
ported from exocrine glands, it was suggested earlier not only
that secretory granules may have the capacity to undergo ho-
motypic fusion but that such fusion may, at least in some
systems, be part of a normal maturation process (54). Such a
scenario would be compatible with an inhibitory effect of Rab3
proteins in fusion events as already inferred for Rab3A from
the study of Rab3A-deficient mice. The only difference would
be that for Rab3D the fusion step controlled by the protein is
not exocytosis but rather a preceding step (granule-granule
fusion).
In summary, our study investigates the potential role of
Rab3D in exocytosis in exocrine glands and mast cells. This
study was prompted by the need for an independent in vivo
assessment of the function of Rab3D. Many previous studies
indicated that Rab3D is central for exocytotic fusion outside of
neuronal and endocrine cells, but all of these studies utilized
indirect approaches that made it difficult to derive definitive
answers. Surprisingly, our data rule out an essential role for
Rab3D in exocytosis. Although Rab3D is probably functionally
redundant with other Rab3 isoforms, its function is not com-
pletely redundant in exocrine cells as shown here because, in
the absence of Rab3D, these cells exhibit a clear maturation
defect in zymogen granules. Future studies will have to exam-
ine the precise genesis of the maturation defect. However,
whatever its nature, Rab3D clearly functions differently than
previously envisioned.
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